Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/26/2025

Cholestyramine Dosing and Administration in Hyperthyroidism

Dosing Guidelines

  • The American College of Cardiology recommends a standard cholestyramine dosing for hyperthyroidism of 8-16 g/day divided into two doses, with lower doses of 2-4 g twice daily often being effective and better tolerated as adjunctive therapy to conventional treatments 1, 2
  • Gradual dose titration is recommended to minimize side effects, typically starting at 2-4 g/day and increasing based on clinical response 3

Administration Considerations

  • Other medications should be taken at least 1 hour before or 4 hours after cholestyramine to avoid impeding their absorption, particularly for thyroid hormone replacement therapy, as cholestyramine can increase TSH in patients receiving such treatment 1, 2

Adverse Effects and Precautions

  • Common side effects of cholestyramine include constipation, dyspepsia, and nausea, and it may exacerbate hypertriglyceridemia 1, 2
  • Cholestyramine is contraindicated in patients with complete biliary obstruction or history of serious hypersensitivity to the medication 2
  • Post-marketing reports include increased TSH in patients receiving thyroid hormone replacement therapy, bowel obstruction, dysphagia, esophageal obstruction, and fecal impaction 1

Monitoring

  • Assess for common side effects, particularly gastrointestinal symptoms, during cholestyramine treatment 1, 2